内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2020 ADA/EASD共识报告：糖尿病精准医疗

2020-06-20 美国糖尿病学会 Diabetes Care . 2020 Jul;43(7):1617-1635.

糖尿病

2020年6月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)共同发布了糖尿病精准医疗共识。本文主要介绍了糖尿病精准医疗基础，同时强调了实现其潜力还有待去实现的事情。

中文标题：

2020 ADA/EASD共识报告：糖尿病精准医疗

英文标题：

Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

发布机构：

美国糖尿病学会

发布日期：

2020-06-20

简要介绍：

2020年6月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)共同发布了糖尿病精准医疗共识。本文主要介绍了糖尿病精准医疗基础，同时强调了实现其潜力还有待去实现的事情。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ADA_EASD共识报告：糖尿病精准医疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=546671c001930176, title=2020 ADA/EASD共识报告：糖尿病精准医疗, enTitle=Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), guiderFrom=Diabetes Care . 2020 Jul;43(7):1617-1635., authorId=0, author=, summary=2020年6月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)共同发布了糖尿病精准医疗共识。本文主要介绍了糖尿病精准医疗基础，同时强调了实现其潜力还有待去实现的事情。, cover=https://img.medsci.cn/2020630/1593527385308_2020535.jpg, journalId=0, articlesId=null, associationId=54, associationName=美国糖尿病学会, associationIntro=美国糖尿病协会县美国重要的非赢利性卫生姐织，旨在提供有关糖尿病的研究进展和信息，促进糖尿病的科研、教育、诊疗等，关注一切与糖尿病有关的事务。协会成立千 1940年，以预防和治疗糖尿病，改善所有糖尿病患者生活质量为目标。一年一度的全球糖尿病领域最大规模的盛会&mdash;&mdash;美国糖尿病协会（ADA)年会于每年的6月如期而至，每年将有来自世界各地的13000名研究者、医生及其他专业人士莅临，共同分享糖尿病领域前沿研究、治疗建议以及治疗新趋势，聚焦糖尿病领域基础研究与临床实践的最新进展，公布最新临床试验结果，关注如何将研究成果应用于临床实践。, copyright=0, guiderPublishedTime=Sat Jun 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年6月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)共同发布了糖尿病精准医疗共识。本文主要介绍了糖尿病精准医疗基础，同时强调了实现其潜力还有待去实现的事情。</p> </div> </div> </div>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6565, appHits=781, showAppHits=0, pcHits=1458, showPcHits=5784, likes=9, shares=44, comments=31, approvalStatus=1, publishedTime=Tue Jun 30 23:07:42 CST 2020, publishedTimeString=2020-06-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Jun 30 22:44:50 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 19:15:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ADA_EASD共识报告：糖尿病精准医疗.pdf)])
2020 ADA_EASD共识报告：糖尿病精准医疗.pdf
下载请点击：
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080798, encodeId=ad321080e98ef, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:59:34 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016351, encodeId=98191016351ed, content=感谢，很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f325600092, createdName=ms3000000221608034, createdTime=Fri Sep 10 15:36:26 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001966, encodeId=a6681001966f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/adde6cc8f91d4e0da9835be0e04d1d33/9c1faada37824c05b058ffec82885d39.jpg, createdBy=edd75555252, createdName=钟哥123, createdTime=Fri Jul 23 11:44:36 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973590, encodeId=6dac9e35902b, content=感谢分享，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=@医路前行@, createdTime=Mon Jun 14 23:08:32 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956654, encodeId=4b4495665476, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a65480110, createdName=katsuki, createdTime=Tue Apr 13 18:22:35 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-12-16 ms3000001530930540

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080798, encodeId=ad321080e98ef, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:59:34 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016351, encodeId=98191016351ed, content=感谢，很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f325600092, createdName=ms3000000221608034, createdTime=Fri Sep 10 15:36:26 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001966, encodeId=a6681001966f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/adde6cc8f91d4e0da9835be0e04d1d33/9c1faada37824c05b058ffec82885d39.jpg, createdBy=edd75555252, createdName=钟哥123, createdTime=Fri Jul 23 11:44:36 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973590, encodeId=6dac9e35902b, content=感谢分享，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=@医路前行@, createdTime=Mon Jun 14 23:08:32 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956654, encodeId=4b4495665476, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a65480110, createdName=katsuki, createdTime=Tue Apr 13 18:22:35 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-09-10 ms3000000221608034

    感谢，很不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080798, encodeId=ad321080e98ef, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:59:34 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016351, encodeId=98191016351ed, content=感谢，很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f325600092, createdName=ms3000000221608034, createdTime=Fri Sep 10 15:36:26 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001966, encodeId=a6681001966f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/adde6cc8f91d4e0da9835be0e04d1d33/9c1faada37824c05b058ffec82885d39.jpg, createdBy=edd75555252, createdName=钟哥123, createdTime=Fri Jul 23 11:44:36 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973590, encodeId=6dac9e35902b, content=感谢分享，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=@医路前行@, createdTime=Mon Jun 14 23:08:32 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956654, encodeId=4b4495665476, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a65480110, createdName=katsuki, createdTime=Tue Apr 13 18:22:35 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-07-23 钟哥123

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080798, encodeId=ad321080e98ef, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:59:34 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016351, encodeId=98191016351ed, content=感谢，很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f325600092, createdName=ms3000000221608034, createdTime=Fri Sep 10 15:36:26 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001966, encodeId=a6681001966f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/adde6cc8f91d4e0da9835be0e04d1d33/9c1faada37824c05b058ffec82885d39.jpg, createdBy=edd75555252, createdName=钟哥123, createdTime=Fri Jul 23 11:44:36 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973590, encodeId=6dac9e35902b, content=感谢分享，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=@医路前行@, createdTime=Mon Jun 14 23:08:32 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956654, encodeId=4b4495665476, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a65480110, createdName=katsuki, createdTime=Tue Apr 13 18:22:35 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-06-14 @医路前行@

    感谢分享，好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080798, encodeId=ad321080e98ef, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=383f5611431, createdName=ms3000001530930540, createdTime=Thu Dec 16 16:59:34 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016351, encodeId=98191016351ed, content=感谢，很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f325600092, createdName=ms3000000221608034, createdTime=Fri Sep 10 15:36:26 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001966, encodeId=a6681001966f3, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210723/adde6cc8f91d4e0da9835be0e04d1d33/9c1faada37824c05b058ffec82885d39.jpg, createdBy=edd75555252, createdName=钟哥123, createdTime=Fri Jul 23 11:44:36 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973590, encodeId=6dac9e35902b, content=感谢分享，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=@医路前行@, createdTime=Mon Jun 14 23:08:32 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956654, encodeId=4b4495665476, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74a65480110, createdName=katsuki, createdTime=Tue Apr 13 18:22:35 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-04-13 katsuki

    #学习#

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中国成人糖尿病前期干预的专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2020-05-30

糖尿病的精准医学：美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告

美国糖尿病学会(ADA,American Diabetes Association) · 2020-06-23

日本儿童和青少年1型糖尿病患者连续血糖监测衍生指标国际共识的个性化建议

暂未更新 · 2020-06-08

2020 ADA：成人T2DM自我管理教育和支持共识

美国糖尿病学会(ADA,American Diabetes Association) · 2020-06-13

2020 实践建议：COVID-19患者糖尿病的管理

国外内分泌相关专家小组（统称） · 2020-04-23

2020 台湾专家共识：糖尿病黄斑水肿的管理

中国眼科相关专家组（统称） · 2020-04-28

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01